BHF Brighthouse Financial Inc

• Estimated combined risk-based capital ("RBC") ratio of approximately 440%; holding company liquid assets of $1.0 billion
• The company repurchased $488 million of its common stock in full year 2022, reducing shares outstanding relative to year-end 2021 by 12%; repurchased an additional $27 million year-to-date through February 7, 2023
• Record annuity sales for full year 2022 of $11.5 billion, driven by strong sales of fixed deferred annuities
• Total life sales of $80 million for full year 2022
• Fourth quarter 2022 net loss available to shareholders of $967 million, or $14.01 per diluted share
• Fourth quarter 2022 adjusted earnings, less notable items*, of $245 million, or $3.51 per diluted share

Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today its financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter and Full Year 2022 Results

The company reported a net loss available to shareholders of $967 million in the fourth quarter of 2022, or $14.01 per diluted share, compared with net income available to shareholders of $42 million in the fourth quarter of 2021. During the quarter, as a result of market performance, the value of our hedges decreased, as expected. Due to being accounted for as insurance liabilities as required under U.S. GAAP accounting, certain corresponding liabilities are less sensitive to market movements and, therefore, did not fully offset the decrease in the value of our hedges.

The company ended the fourth quarter of 2022 with common stockholders' equity ("book value") of $3.8 billion, or $55.11 per common share, and book value, excluding accumulated other comprehensive income ("AOCI") of $9.7 billion, or $142.04 per common share.

For the fourth quarter of 2022, the company reported adjusted earnings* of $242 million, or $3.46 per diluted share, compared with adjusted earnings of $323 million, or $4.02 per diluted share, in the fourth quarter of 2021.

_______

* Information regarding the non-GAAP and other financial measures included in this news release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Non-GAAP and Other Financial Disclosures discussion below, as well as in the tables that accompany this news release and/or the Fourth Quarter 2022 Brighthouse Financial, Inc. Financial Supplement and/or the Fourth Quarter and Full Year 2022 Brighthouse Financial, Inc. Earnings Call Presentation (which are available on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com). Additional information regarding notable items can be found on the last page of this news release.

Adjusted earnings for the quarter reflected $3 million of net unfavorable notable items, or $0.04 per diluted share, including:

• $39 million unfavorable impact related to actuarial items, including a reinsurance recapture and refinements of certain actuarial assumptions, and

• $15 million unfavorable impact for establishment costs related to planned technology and other expenses associated with the company's separation from its former parent company, offset by

• $51 million favorable impact related to the resolution of prior year tax matters.

Corporate expenses in the fourth quarter of 2022 were $243 million, up from $217 million in the third quarter of 2022, both on a pre-tax basis.

The company reported record annuity sales in 2022, which increased 36% quarter-over-quarter and 26% year-over-year, driven by strong sales of fixed deferred annuities. Annuity sales decreased 14% sequentially, primarily driven by lower sales of fixed deferred and Shield Level annuities. Life sales decreased 37% quarter-over-quarter and 28% year-over-year, as a result of the prevailing macroeconomic headwinds. Life sales increased 16% sequentially.

On a full year basis, the company reported a net loss available to shareholders of $99 million in 2022, or $1.36 per diluted share, compared with a net loss available to shareholders of $197 million in 2021, or $2.36 per diluted share. Full year 2022 adjusted earnings, less notable items*, were $804 million, or $10.93 per diluted share, compared with full year 2021 adjusted earnings, less notable items, of $1,816 million, or $21.50 per diluted share. The adjusted earnings results were mainly due to lower alternative investment returns year-over-year.

During the fourth quarter of 2022, the company repurchased $93 million of its common stock, and for the full year 2022 it repurchased $488 million of its common stock and reduced shares outstanding relative to year-end 2021 by 12%. Year-to-date through February 7, 2023, the company has repurchased an additional $27 million of its common stock, on a trade date basis.

"I am proud of the strong results that Brighthouse Financial delivered in the fourth quarter of 2022, including maintaining a robust capital and liquidity position, achieving 36% quarter-over-quarter growth in annuity sales and continuing to return capital to our shareholders through our common stock repurchase program," said Eric Steigerwalt, president and CEO, Brighthouse Financial.

"Additionally, 2022 was another strong year for Brighthouse Financial as we continued to execute our focused strategy, despite the challenging economic environment," Steigerwalt continued. "Among our many achievements, we delivered record annuity sales of $11.5 billion for the full year, further demonstrating the strength and complementary nature of our product suite. I am also extremely pleased that we completed the implementation of our future state operations and technology platform, which marks the end of establishment costs and allows us to further increase our focus on growth, the evolution of our business mix and supporting our distribution franchise. As we look ahead to 2023 and beyond, we believe that we remain well positioned to continue executing our strategy and delivering long-term value for our shareholders."

Key Metrics (Unaudited, dollars in millions except share and per share amounts)

 

 

As of or For the Three Months Ended

 

For the Year Ended

 

 

December 31, 2022

 

December 31, 2021

 

December 31, 2022

 

December 31, 2021

 

 

Total

 

Per share

 

Total

 

Per share

 

Total

 

Per share

 

Total

 

Per share

Net income (loss) available to shareholders (1)

 

$(967)

 

$(14.01)

 

$42

 

$0.51

 

$(99)

 

$(1.36)

 

$(197)

 

$(2.36)

Adjusted earnings (1)

 

$242

 

$3.46

 

$323

 

$4.02

 

$657

 

$8.93

 

$1,593

 

$18.86

Adjusted earnings, less notable items (1)

 

$245

 

$3.51

 

$416

 

$5.18

 

$804

 

$10.93

 

$1,816

 

$21.50

Weighted average common shares outstanding - diluted (1)

 

69,765,118

 

N/A

 

80,244,577

 

N/A

 

73,581,168

 

N/A

 

84,466,157

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Book value

 

$3,763

 

$55.11

 

$14,443

 

$185.48

 

 

 

 

 

 

 

 

Book value, excluding AOCI

 

$9,698

 

$142.04

 

$10,271

 

$131.90

 

 

 

 

 

 

 

 

Ending common shares outstanding

 

68,278,068

 

N/A

 

77,870,072

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Results by Segment and Corporate & Other (Unaudited, in millions)

 

 

For the Three Months Ended

ADJUSTED EARNINGS

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

Annuities

 

$286

 

$125

 

$390

Life (1)

 

$(20)

 

$(7)

 

$67

Run-off (1)

 

$(120)

 

$(21)

 

$(45)

Corporate & Other (1)

 

$96

 

$—

 

$(89)

 

 

 

 

 

 

 

(1) The company uses the term “adjusted loss” throughout this news release to refer to negative adjusted earnings values.

Sales (Unaudited, in millions)

 

 

For the Three Months Ended

 

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

Annuities (1)

 

$3,211

 

$3,721

 

$2,359

Life

 

$22

 

$19

 

$35

 

 

 

 

 

 

 

(1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were $161 million for the fourth quarter of 2022, $213 million for the third quarter of 2022 and $292 million for the fourth quarter of 2021.

Annuities

Adjusted earnings in the Annuities segment were $286 million in the current quarter, compared with adjusted earnings of $390 million in the fourth quarter of 2021 and adjusted earnings of $125 million in the third quarter of 2022.

There were no notable items in the current quarter. The fourth quarter of 2021 included a $29 million favorable notable item related to a valuation system conversion associated with the company's transition to its future state platform. The third quarter of 2022 included a $45 million unfavorable notable item related to the annual actuarial review.

On a quarter-over-quarter basis, adjusted earnings, less notable items, reflect lower fees, partially offset by lower expenses. On a sequential basis, adjusted earnings, less notable items, reflect lower reserves, lower deferred acquisition costs ("DAC") amortization and higher net investment income, partially offset by lower fees and higher expenses.

As mentioned above, annuity sales increased 36% quarter-over-quarter and 26% year-over-year, driven by strong sales of fixed deferred annuities. Annuity sales decreased 14% sequentially, primarily driven by lower sales of fixed deferred and Shield Level annuities.

Life

The Life segment had an adjusted loss of $20 million in the current quarter, compared with adjusted earnings of $67 million in the fourth quarter of 2021 and an adjusted loss of $7 million in the third quarter of 2022.

The current quarter included a $15 million unfavorable notable item and the fourth quarter of 2021 included a $9 million favorable notable item, both related to refinements of certain actuarial assumptions. The third quarter of 2022 included a $5 million unfavorable item related to the annual actuarial review.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects lower net investment income and higher DAC amortization. On a sequential basis, the adjusted loss, less notable items, reflects higher DAC amortization and higher expenses, partially offset by higher net investment income.

As mentioned above, life sales decreased 37% quarter-over-quarter and 28% year-over-year, as a result of the prevailing macroeconomic headwinds. Life sales increased 16% sequentially.

Run-off

The Run-off segment had an adjusted loss of $120 million in the current quarter, compared with an adjusted loss of $45 million in the fourth quarter of 2021 and an adjusted loss of $21 million in the third quarter of 2022.

The current quarter included a $24 million unfavorable notable item and the fourth quarter of 2021 included $51 million of unfavorable notable items, both related to reinsurance recaptures. The third quarter of 2022 included a $128 million favorable notable item related to the annual actuarial review.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects lower net investment income, partially offset by a higher underwriting margin and lower expenses. On a sequential basis, the adjusted loss, less notable items, reflects higher net investment income, partially offset by higher expenses.

Corporate & Other

Corporate & Other had adjusted earnings of $96 million in the current quarter, compared with an adjusted loss of $89 million in the fourth quarter of 2021 and breakeven adjusted earnings in the third quarter of 2022.

The current quarter included $36 million of net favorable notable items related to the resolution of prior year tax matters, partially offset by establishment costs. The fourth quarter of 2021 included $80 million of unfavorable notable items related to debt repayment costs associated with the repurchase by the company of a portion of its outstanding senior notes, as well as establishment costs. The third quarter of 2022 included $22 million of net favorable notable items related to an actuarial item, partially offset by establishment costs.

On a quarter-over-quarter basis, the adjusted earnings, less notable items, reflect lower expenses and higher net investment income. On a sequential basis, the adjusted earnings, less notable items, reflect a higher tax benefit and lower expenses.

Net Investment Income and Adjusted Net Investment Income (Unaudited, in millions)

 

 

For the Three Months Ended

 

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

Net investment income

 

$1,049

 

$877

 

$1,201

Adjusted net investment income

 

$1,082

 

$900

 

$1,206

Net Investment Income

Net investment income was $1,049 million and adjusted net investment income* was $1,082 million in the current quarter. On a quarter-over-quarter basis, adjusted net investment income decreased $124 million and on a sequential basis increased $182 million. The quarter-over-quarter results were primarily driven by lower alternative investment income, partially offset by asset growth. The sequential increase was driven by higher alternative investment income and asset growth.

The net investment income yield was 3.79% during the quarter.

Statutory Capital and Liquidity (Unaudited, in billions)

 

 

As of

 

 

December 31,

2022 (1)

 

September 30, 2022

 

December 31, 2021

Statutory combined total adjusted capital

 

$8.1

 

$8.0

 

$9.4

 

 

 

 

 

 

 

(1) Reflects preliminary statutory results as of December 31, 2022.

Capitalization

As of December 31, 2022:

• Statutory combined total adjusted capital(1) ("TAC") increased sequentially to approximately $8.1 billion, primarily driven by strong variable annuity ("VA") results related to positive market performance, partially offset by the impact from the VA valuation system conversion and annual VA assumption review in the fourth quarter

• Estimated combined RBC ratio(1) of approximately 440%, which reflects the above-mentioned sequential change in TAC along with additional capital requirements associated with growth in new business

• Holding company liquid assets were approximately $1.0 billion

_______________

(1) Reflects preliminary statutory results as of December 31, 2022.

Earnings Conference Call

Brighthouse Financial will hold a conference call and audio webcast to discuss its financial results for the fourth quarter and full year 2022 at 8:00 a.m. Eastern Time on Friday, February 10, 2023. In connection with this call, the company has prepared a presentation for use with investors and other members of the investment community. This presentation is available on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com.

To listen to the audio webcast via the internet and to access the related presentation, please visit the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com. To join the conference call via telephone as a participant, please register in advance at https://register.vevent.com/register/BId988d5ea0c0e4065b3cddb72a77d4f11.

A replay of the conference call will be made available until Friday, March 3, 2023, on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com.

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) is on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,(1) we specialize in products designed to help people protect what they've earned and ensure it lasts. Learn more at brighthousefinancial.com.

(1) Ranked by 2021 admitted assets. Best's Review®: Top 200 U.S. Life/Health Insurers. AM Best, 2022.

Note Regarding Forward-Looking Statements

This news release and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as "anticipate," "estimate," "expect," "project," "may," "will," "could," "intend," "goal," "target," "guidance," "forecast," "preliminary," "objective," "continue," "aim," "plan," "believe" and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, financial projections, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, as well as trends in operating and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of Brighthouse Financial. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others: differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models; higher risk management costs and exposure to increased market risk due to guarantees within certain of our products; the effectiveness of our variable annuity exposure risk management strategy and the impact of such strategy on volatility in our profitability measures and negative effects on our statutory capital; material differences from actual outcomes compared to the sensitivities calculated under certain scenarios and sensitivities that we may utilize in connection with our variable annuity risk management strategies; the impact of interest rates on our future ULSG policyholder obligations and net income volatility; the impact of the ongoing COVID-19 pandemic; the potential material adverse effect of changes in accounting standards, practices or policies applicable to us, including changes in the accounting for long-duration contracts; loss of business and other negative impacts resulting from a downgrade or a potential downgrade in our financial strength or credit ratings; the availability of reinsurance and the ability of the counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder; heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities and name recognition; our ability to market and distribute our products through distribution channels; any failure of third parties to provide services we need, any failure of the practices and procedures of such third parties and any inability to obtain information or assistance we need from third parties; the ability of our subsidiaries to pay dividends to us, and our ability to pay dividends to our shareholders and repurchase our common stock; the risks associated with climate change; the adverse impact on liabilities for policyholder claims as a result of extreme mortality events; the impact of adverse capital and credit market conditions, including with respect to our ability to meet liquidity needs and access capital; the impact of economic conditions in the capital markets and the U.S. and global economy, as well as geo-political events, military actions or catastrophic events, on our investment portfolio, including on realized and unrealized losses and impairments, net investment spread and net investment income; the impact of events that adversely affect issuers, guarantors or collateral relating to our investments or our derivatives counterparties, on impairments, valuation allowances, reserves, net investment income and changes in unrealized gain or loss positions; the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations; the potential material negative tax impact of potential future tax legislation that could make some of our products less attractive to consumers; the effectiveness of our policies and procedures in managing risk; the loss or disclosure of confidential information, damage to our reputation and impairment of our ability to conduct business effectively as a result of any failure in cyber- or other information security systems; whether all or any portion of the tax consequences of our separation from MetLife, Inc. (“MetLife”) are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us; the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements or disagreements regarding MetLife’s or our obligations under our other agreements; and other factors described from time to time in documents that we file with the U.S. Securities and Exchange Commission (the "SEC").

For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our Annual Report on Form 10-K for the year ended December 31, 2021, particularly in the sections entitled "Risk Factors" and "Quantitative and Qualitative Disclosures About Market Risk," as well as in our other subsequent filings with the SEC. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

Non-GAAP and Other Financial Disclosures

Our definitions of non-GAAP and other financial measures may differ from those used by other companies.

Non-GAAP Financial Disclosures

We present certain measures of our performance that are not calculated in accordance with accounting principles generally accepted in the United States of America, also known as "GAAP." We believe that these non-GAAP financial measures enhance the understanding of our performance by the investor community by highlighting the results of operations and the underlying profitability drivers of our business.

The following non-GAAP financial measures, previously referred to as operating measures, should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

 

 

Non-GAAP financial measures:

Most directly comparable GAAP financial measures:

adjusted earnings

net income (loss) available to shareholders (1)

adjusted earnings, less notable items

net income (loss) available to shareholders (1)

adjusted revenues

revenues

adjusted expenses

expenses

adjusted earnings per common share

earnings per common share, diluted (1)

adjusted earnings per common share, less notable items

earnings per common share, diluted (1)

adjusted return on common equity

return on common equity (2)

adjusted return on common equity, less notable items

return on common equity (2)

adjusted net investment income

net investment income

__________________

 

(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share.

(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity.

Reconciliations to the most directly comparable historical GAAP measures are included for those measures which are presented herein. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss) available to shareholders.

Adjusted Earnings, Adjusted Revenues and Adjusted Expenses

Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. This financial measure, which may be positive or negative, focuses on our primary businesses by excluding the impact of market volatility, which could distort trends.

Adjusted earnings reflects adjusted revenues less (i) adjusted expenses, (ii) provision for income tax expense (benefit), (iii) net income (loss) attributable to noncontrolling interests and (iv) preferred stock dividends. Provided below are the adjustments to GAAP revenues and GAAP expenses used to calculate adjusted revenues and adjusted expenses, respectively.

The following are significant items excluded from total revenues in calculating the adjusted revenues component of adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) ("NDGL") except earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment ("Investment Hedge Adjustments"); and

• Certain variable annuity GMIB fees ("GMIB Fees").

The following are significant items excluded from total expenses in calculating the adjusted expenses component of adjusted earnings:

• Amounts associated with benefits related to GMIBs ("GMIB Costs");

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets ("Market Value Adjustments"); and

• Amortization of DAC and value of business acquired ("VOBA") related to (i) net investment gains (losses), (ii) net derivative gains (losses) and (iii) GMIB Fees and GMIB Costs.

The tax impact of the adjustments discussed above is calculated net of the statutory tax rate, which could differ from our effective tax rate.

Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance.

Adjusted Earnings per Common Share and Adjusted Return on Common Equity

Adjusted earnings per common share and adjusted return on common equity are measures used by management to evaluate the execution of our business strategy and align such strategy with our shareholders' interests.

Adjusted earnings per common share is defined as adjusted earnings for the period divided by the weighted average number of fully diluted shares of common stock outstanding for the period. The weighted average common shares outstanding used to calculate adjusted earnings per share will differ from such shares used to calculate diluted net income (loss) available to shareholders per common share when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.

Adjusted return on common equity is defined as total annual adjusted earnings on a four quarter trailing basis, divided by the simple average of the most recent five quarters of total Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI.

Adjusted Net Investment Income

We present adjusted net investment income to measure our performance for management purposes, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents GAAP net investment income plus Investment Hedge Adjustments.

Other Financial Disclosures

Corporate Expenses

Corporate expenses includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation; and excludes establishment costs.

Notable items

Certain of the non-GAAP measures described above may be presented further adjusted to exclude notable items. Notable items reflect the unfavorable (favorable) after-tax impact on our results of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items and non-GAAP measures, less notable items is intended to help investors better understand our results and to evaluate and forecast those results.

Book Value per Common Share and Book Value per Common Share, excluding AOCI

Brighthouse uses the term "book value" to refer to "Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI." Book value per common share is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI, divided by ending common shares outstanding. Book value per common share, excluding AOCI, is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI, divided by ending common shares outstanding.

CTE98

CTE98 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst two percent of a set of capital market scenarios over the life of the contracts.

Holding Company Liquid Assets

Holding company liquid assets include liquid assets in Brighthouse Financial, Inc., Brighthouse Holdings, LLC, and Brighthouse Services, LLC. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include assets held in trust.

Total Adjusted Capital

Total adjusted capital primarily consists of statutory capital and surplus, as well as the statutory asset valuation reserve. When referred to as “combined,” represents that of our insurance subsidiaries as a whole.

Sales

Life insurance sales consist of 100 percent of annualized new premium for term life, first-year paid premium for whole life, universal life, and variable universal life, and total paid premium for indexed universal life. We exclude company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life.

Annuity sales consist of 100 percent of direct statutory premiums, except for fixed index annuity sales, which represents 100 percent of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Annuity sales exclude certain internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

Net Investment Income Yield

Similar to adjusted net investment income, we present net investment income yields as a performance measure we believe enhances the understanding of our investment portfolio results. Net investment income yields are calculated on adjusted net investment income as a percentage of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. Investment fee and expense yields are calculated as investment fees and expenses as a percentage of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.

Normalized Statutory Earnings (Loss)

Normalized statutory earnings (loss) is used by management to measure our insurance companies’ ability to pay future distributions and is reflective of whether our hedging program functions as intended. Normalized statutory earnings (loss) is calculated as statutory pre-tax net gain (loss) from operations adjusted for the favorable or unfavorable impacts of (i) net realized capital gains (losses), (ii) the change in total asset requirement at CTE98, net of the change in our variable annuity reserves, and (iii) unrealized gains (losses) associated with our variable annuities and other equity risk management strategies. Normalized statutory earnings (loss) may be further adjusted for certain unanticipated items that impacted our results in order to help management and investors better understand, evaluate and forecast those results.

Risk-Based Capital Ratio

The risk-based capital ratio is a method of measuring an insurance company’s capital, taking into consideration its relative size and risk profile, in order to ensure compliance with minimum regulatory capital requirements set by the National Association of Insurance Commissioners. When referred to as “combined,” represents that of our insurance subsidiaries as a whole. The reporting of our combined risk-based capital ratio is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

Condensed Statements of Operations (Unaudited, in millions)

 

 

For the Three Months Ended

Revenues

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

Premiums

 

$167

 

$162

 

$168

Universal life and investment-type product policy fees

 

733

 

783

 

906

Net investment income

 

1,049

 

877

 

1,201

Other revenues

 

100

 

121

 

101

Revenues before NIGL and NDGL

 

2,049

 

1,943

 

2,376

Net investment gains (losses)

 

(69)

 

(45)

 

(23)

Net derivative gains (losses)

 

(1,526)

 

(416)

 

(337)

Total revenues

 

$454

 

$1,482

 

$2,016

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

Policyholder benefits and claims

 

$905

 

$1,246

 

$823

Interest credited to policyholder account balances

 

400

 

430

 

315

Amortization of DAC and VOBA

 

(16)

 

179

 

127

Interest expense on debt

 

39

 

38

 

41

Other expenses

 

450

 

457

 

661

Total expenses

 

1,778

 

2,350

 

1,967

Income (loss) before provision for income tax

 

(1,324)

 

(868)

 

49

Provision for income tax expense (benefit)

 

(384)

 

(193)

 

(15)

Net income (loss)

 

(940)

 

(675)

 

64

Less: Net income (loss) attributable to noncontrolling interests

 

1

 

2

 

1

Net income (loss) attributable to Brighthouse Financial, Inc.

 

(941)

 

(677)

 

63

Less: Preferred stock dividends

 

26

 

25

 

21

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders

 

$(967)

 

$(702)

 

$42

Condensed Balance Sheets (Unaudited, in millions)

 

 

As of

ASSETS

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

Investments:

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

$75,577

 

$75,271

 

$87,582

Equity securities

 

89

 

100

 

101

Mortgage loans

 

22,936

 

22,089

 

19,850

Policy loans

 

1,282

 

1,274

 

1,264

Limited partnerships and limited liability companies

 

4,775

 

4,607

 

4,271

Short-term investments

 

1,081

 

1,130

 

1,841

Other invested assets

 

2,852

 

4,033

 

3,316

Total investments

 

108,592

 

108,504

 

118,225

Cash and cash equivalents

 

4,115

 

4,793

 

4,474

Accrued investment income

 

885

 

909

 

724

Reinsurance recoverables

 

18,514

 

17,116

 

15,340

Premiums and other receivables

 

752

 

761

 

754

DAC and VOBA

 

5,659

 

5,639

 

5,377

Current income tax recoverable

 

38

 

18

 

—

Deferred income tax asset

 

1,754

 

1,619

 

—

Other assets

 

442

 

446

 

482

Separate account assets

 

84,965

 

81,836

 

114,464

Total assets

 

$225,716

 

$221,641

 

$259,840

LIABILITIES AND EQUITY

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Future policy benefits

 

$42,216

 

$41,786

 

$43,807

Policyholder account balances

 

74,836

 

71,323

 

66,851

Other policy-related balances

 

3,400

 

3,364

 

3,457

Payables for collateral under securities loaned and other transactions

 

4,560

 

6,532

 

6,269

Long-term debt

 

3,156

 

3,156

 

3,157

Current income tax payable

 

—

 

—

 

62

Deferred income tax liability

 

—

 

—

 

1,062

Other liabilities

 

7,056

 

7,765

 

4,504

Separate account liabilities

 

84,965

 

81,836

 

114,464

Total liabilities

 

220,189

 

215,762

 

243,633

Equity

 

 

 

 

 

 

Preferred stock, at par value

 

—

 

—

 

—

Common stock, at par value

 

1

 

1

 

1

Additional paid-in capital

 

14,075

 

14,095

 

14,154

Retained earnings (deficit)

 

(637)

 

304

 

(642)

Treasury stock

 

(2,042)

 

(1,949)

 

(1,543)

Accumulated other comprehensive income (loss)

 

(5,935)

 

(6,637)

 

4,172

Total Brighthouse Financial, Inc.’s stockholders’ equity

 

5,462

 

5,814

 

16,142

Noncontrolling interests

 

65

 

65

 

65

Total equity

 

5,527

 

5,879

 

16,207

Total liabilities and equity

 

$225,716

 

$221,641

 

$259,840

Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings per Common Share and Adjusted Earnings, Less Notable Items per Common Share (Unaudited, in millions except per share data)

 

 

For the Three Months Ended

 

For the Year Ended

ADJUSTED EARNINGS, LESS NOTABLE ITEMS

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

 

December 31, 2022

 

December 31, 2021

Net income (loss) available to shareholders

 

$(967)

 

$(702)

 

$42

 

$(99)

 

$(197)

Less: Net investment gains (losses)

 

(69)

 

(45)

 

(23)

 

(248)

 

(59)

Less: Net derivative gains (losses), excluding investment hedge adjustments

 

(1,559)

 

(439)

 

(342)

 

233

 

(2,490)

Less: GMIB Fees and GMIB Costs

 

(57)

 

(336)

 

89

 

(538)

 

203

Less: Amortization of DAC and VOBA

 

158

 

(212)

 

(74)

 

(489)

 

74

Less: Market value adjustments and other

 

(3)

 

21

 

(5)

 

86

 

9

Less: Provision for income tax (expense) benefit on reconciling adjustments

 

321

 

212

 

74

 

200

 

473

Adjusted earnings

 

242

 

97

 

323

 

657

 

1,593

Less: Notable items

 

(3)

 

100

 

(93)

 

(147)

 

(223)

Adjusted earnings, less notable items

 

$245

 

$(3)

 

$416

 

$804

 

$1,816

 

 

 

 

 

 

 

 

 

 

 

ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1)

 

 

 

 

 

 

 

 

 

 

Net income (loss) available to shareholders per common share

 

$(14.01)

 

$(9.82)

 

$0.51

 

$(1.36)

 

$(2.36)

Less: Net investment gains (losses)

 

(1.00)

 

(0.63)

 

(0.29)

 

(3.40)

 

(0.70)

Less: Net derivative gains (losses), excluding investment hedge adjustments

 

(22.58)

 

(6.14)

 

(4.26)

 

3.19

 

(29.72)

Less: GMIB Fees and GMIB Costs

 

(0.83)

 

(4.70)

 

1.11

 

(7.37)

 

2.42

Less: Amortization of DAC and VOBA

 

2.29

 

(2.96)

 

(0.92)

 

(6.70)

 

0.88

Less: Market value adjustments and other

 

(0.04)

 

0.29

 

(0.06)

 

1.18

 

0.11

Less: Provision for income tax (expense) benefit on reconciling adjustments

 

4.65

 

2.96

 

0.92

 

2.74

 

5.65

Less: Impact of inclusion of dilutive shares

 

0.04

 

0.01

 

—

 

—

 

0.15

Adjusted earnings per common share

 

3.46

 

1.35

 

4.02

 

8.93

 

18.86

Less: Notable items

 

(0.04)

 

1.39

 

(1.16)

 

(2.00)

 

(2.64)

Adjusted earnings, less notable items per common share

 

$3.51

 

$(0.04)

 

$5.18

 

$10.93

 

$21.50

 

 

 

 

 

 

 

 

 

 

 

(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Reconciliation of Net Investment Income to Adjusted Net Investment Income (Unaudited, in millions)

 

 

For the Three Months Ended

 

For the Year Ended

 

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

 

December 31, 2022

 

December 31, 2021

Net investment income

 

$1,049

 

$877

 

$1,201

 

$4,138

 

$4,881

Less: Investment hedge adjustments

 

(33)

 

(23)

 

(5)

 

(71)

 

(21)

Adjusted net investment income

 

$1,082

 

$900

 

$1,206

 

$4,209

 

$4,902

Notable Items (Unaudited, in millions)

 

 

For the Three Months Ended

 

For the Year Ended

NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS

 

December 31, 2022

 

September 30, 2022

 

December 31, 2021

 

December 31, 2022

 

December 31, 2021

Actuarial items and other insurance adjustments

 

$39

 

$(117)

 

$13

 

$145

 

$86

Establishment costs

 

15

 

17

 

21

 

53

 

78

Debt repayment costs

 

—

 

—

 

59

 

—

 

59

Prior year tax matters

 

(51)

 

—

 

—

 

(51)

 

—

Total notable items (1)

 

$3

 

$(100)

 

$93

 

$147

 

$223

 

 

 

 

 

 

 

 

 

 

 

NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER

 

 

 

 

 

 

 

 

 

 

Annuities

 

$—

 

$45

 

$(29)

 

$59

 

$(71)

Life

 

15

 

5

 

(9)

 

31

 

(12)

Run-off

 

24

 

(128)

 

51

 

94

 

169

Corporate & Other

 

(36)

 

(22)

 

80

 

(37)

 

137

Total notable items (1)

 

$3

 

$(100)

 

$93

 

$147

 

$223

 

 

 

 

 

(1) See Non-GAAP and Other Financial Disclosures discussion in this news release.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005460/en/

FOR INVESTORS Dana Amante (980) 949-3073 damante@brighthousefinancial.com

FOR MEDIA Deon Roberts (980) 949-3071 deon.roberts@brighthousefinancial.com